Pilocarpine Hydrochloride Tablet, Film Coated
Product Images NDC 69292-265

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pilocarpine Hydrochloride (NDC 69292-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amici Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Child-pugh-scoring-table-1 (Child Pugh Scoring Table 1)

Child-pugh-scoring-table-1 (Child Pugh Scoring Table 1)
The text is a chart or table showing clinical and biochemical measurements with points scored for increasing abnormality. It includes measurements for encephalopathy, albumin, bilirubin, and prothrombin time, with different grades of abnormality indicated by the score. It also specifies the measurement of bilirubin for primary biliary cirrhosis.*
FDA Label Image

Head-neck-table-1 (Head Neck Table 1)

FDA Label Image

Head-neck-table-2 (Head Neck Table 2)

FDA Label Image

Pilocarpine-hcl (Pilocarpine HCl)

FDA Label Image

Sjogren-syndrome-table-1 (Sjogren Syndrom Table 1)

FDA Label Image

Sjrogren-syndrome-table-2 (Sjogren Syndrome Table 2)

Sjrogren-syndrome-table-2 (Sjogren Syndrome Table 2)
This appears to be a list of adverse events possibly related to the medication Pilocarpine HCI and a placebo. It is difficult to discern specific information due to the poor quality of the text obtained by . It is recommended to consult the original document or other sources for a more accurate description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.